Makk Pharma Labs Private Limited - Company Profile

It is a chemicals private limited company based in Guntur, Andhra Pradesh, India, established in 2021.
2021 Guntur, Andhra Pradesh, India Active
Last Updated:
Access Report
About Makk Pharma Labs Private Limited

Makk Pharma Labs Private Limited, a active private limited company, was established on 01 June 2021 in Guntur, Andhra Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24290AP2021PTC118416. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹0.10 M.

Its leadership includes Shaik Jasmine (Director), Srinivas Nishanth Cheekatla (Managing Director). Past directors included Mastan Shaik, Shaik Karima. It is based at F No - 2, Lotus Apartment, 1St Line, Bhavani Nagar, Inner Ring Rioad, Guntur, Andhra Pradesh, 522034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290AP2021PTC118416

  • Registration Number

    118416

  • Incorporation Date

    01 June 2021

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 8 Months
Company report

Makk Pharma Labs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Makk Pharma Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Makk Pharma Labs Private Limited?
Current Directors
Name Designation Appointment Date Status
Shaik Jasmine Director 15 Oct 2024 Current
Srinivas Nishanth Cheekatla Managing Director 15 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Oct 2024 Past
Pramod Abcsdd Director 24 Oct 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Makk Pharma Labs.

Enhance accessibility to Makk Pharma Labs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Makk Pharma Labs revenue growth over time
Makk Pharma Labs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Makk Pharma Labs?

Unlock access to Makk Pharma Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Makk Pharma Labs?

Makk Pharma Labs has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Makk Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makk Pharma Labs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Makk Pharma Labs
Recent Activity within the Organization
  • Director Appointment

    Shaik Jasmine was appointed as a Director was appointed as a Director on 15 Oct 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Srinivas Nishanth Cheekatla was appointed as a Managing Director was appointed as a Managing Director on 15 Oct 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Company Incorporation

    Progress on Makk Pharma Labs Private Limited was registered on 01 Jun 2021 with Roc Vijayawada & aged 4 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Makk Pharma Labs Private Limited?

The CIN of Makk Pharma Labs Private Limited is U24290AP2021PTC118416.

Where is Makk Pharma Labs Private Limited headquartered?

Makk Pharma Labs Private Limited is headquartered at F No - 2, Lotus Apartment, 1St Line, Bhavani Nagar, Inner Ring Rioad, Guntur, Andhra Pradesh, 522034.

When was Makk Pharma Labs Private Limited incorporated?

Makk Pharma Labs Private Limited was incorporated on 01 June 2021.

Who are the current directors of Makk Pharma Labs Private Limited?

The current directors of Makk Pharma Labs Private Limited are

What is the primary industry of Makk Pharma Labs Private Limited?

The primary industry of Makk Pharma Labs Private Limited is Chemicals.

Is Makk Pharma Labs Private Limited a listed company?

Makk Pharma Labs Private Limited is unlisted.

What is the capital structure of Makk Pharma Labs Private Limited?

The authorized capital of Makk Pharma Labs Private Limited is ₹10.00 Cr, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available